cupure logo
cancerexpertsuniontestsrevealcaliforniascientistsopenhomebrain

Cancer survival appears to double with common vaccine, researchers say

Cancer survival appears to double with common vaccine, researchers say
A new study finds that combining the COVID vaccine with immunotherapy may nearly double cancer survival rates — patients lived an average of 37.3 months compared to 20.6 months without the vaccine.

Comments

Similar News

Health news